Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 2/20 | 0.71 |
| ▸ | OXER1 | Q8TDS5 | 1/20 | 0.71 |
| ▸ | MGLL | Q99685 | 1/20 | 0.67 |
| ▸ | CNR1 | P21554 | 6/20 | 0.66 |
| ▸ | CNR2 | P34972 | 2/20 | 0.66 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.66 |
| ▸ | MAPT | P10636 | 3/20 | 0.66 |
| ▸ | PPARG | P37231 | 2/20 | 0.66 |
| ▸ | HPGD | P15428 | 2/20 | 0.66 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.66 |
| ▸ | MEN1 | O00255 | 1/20 | 0.66 |
| ▸ | USP2 | O75604 | 1/20 | 0.66 |
| ▸ | LMNA | P02545 | 1/20 | 0.66 |
| ▸ | TP53 | P04637 | 1/20 | 0.66 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.66 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.66 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.66 |
| ▸ | FABP4 | P15090 | 1/20 | 0.66 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.66 |
| ▸ | CASP1 | P29466 | 1/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23152374 | 1.00 | ALOX5 (0.71) | ALOX5OXER1MGLLCNR1CNR2 | |
| SCHEMBL29253889 | 1.00 | ALOX5 (0.71) | ALOX5OXER1MGLLCNR1CNR2 | |
| SCHEMBL7885020 | 1.00 | ALOX5 (0.71) | ALOX5OXER1MGLLCNR1CNR2 | |
| SCHEMBL23821 | 1.00 | ALOX5 (0.71) | ALOX5OXER1MGLLCNR1CNR2 | |
| SCHEMBL7885017 | 1.00 | ALOX5 (0.71) | ALOX5OXER1MGLLCNR1CNR2 | |
| SCHEMBL32662839 | 0.98 | ALOX5 (0.69) | ALOX5OXER1MGLLCNR1CNR2 | |
| Methyl Alcohol SCHEMBL6900401 | 0.98 | ALOX5 (0.69) | ALOX5OXER1MGLLCNR1CNR2 | |
| Methyl Alcohol SCHEMBL6900398 | 0.98 | ALOX5 (0.69) | ALOX5OXER1MGLLCNR1CNR2 | |
| SCHEMBL23143237 | 0.96 | ALOX5 (0.71) | ALOX5OXER1MGLLALDH1A1PPARG | |
| SCHEMBL7170526 | 0.96 | ALOX5 (0.71) | ALOX5OXER1MGLLALDH1A1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 523 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4262368-B1 | WEARABLE PET DEVICES WITH PASSIVE DIFFUSION OF SEMIOCHEMICAL COMPOSITIONS | VIRBAC (FR) | 2026-01-28 | — | — | EP | claimed |
| US-20240335412-A1 | WEARABLE PET DEVICES WITH PASSIVE DIFFUSION OF SEMIOCHEMICAL COMPOSITIONS | VIRBAC (FR) | 2024-10-10 | — | — | US | claimed |
| CN-117264670-B | Diesel antiwear agent and preparation method thereof | 湖南浩润科技有限公司 | 2024-05-10 | — | — | CN | claimed |
| CN-117264670-A | Diesel antiwear agent and preparation method thereof | 湖南浩润科技有限公司 | 2023-12-22 | — | — | CN | claimed |
| EP-4262368-A1 | WEARABLE PET DEVICES WITH PASSIVE DIFFUSION OF SEMIOCHEMICAL COMPOSITIONS | VIRBAC (FR) | 2023-10-25 | — | — | EP | claimed |
| US-20230298758-A1 | Systems and Methods for Evaluating Gestational Progress and Applications Thereof | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY (US) | 2023-09-21 | — | — | US | claimed |
| EP-4241285-A1 | SYSTEMS AND METHODS FOR EVALUATING GESTATIONAL PROGRESS AND APPLICATIONS THEREOF | The Board of Trustees of the Leland Stanford Junior University (US) | 2023-09-13 | — | — | EP | claimed |
| CN-116669712-A | Wearable pet device with passive diffusion of a chemical information composition | 维克公司 | 2023-08-29 | — | — | CN | claimed |
| CN-114796021-A | Composition prepared from Hermetia illucens for resisting speckle and bacteria, and its preparation method | 吴孟昆 | 2022-07-29 | — | — | CN | claimed |
| WO-2022136181-A1 | WEARABLE PET DEVICES WITH PASSIVE DIFFUSION OF SEMIOCHEMICAL COMPOSITIONS | VIRBAC (FR) | 2022-06-30 | — | — | WO | claimed |
| US-20100022645-A1 | PKC-Activating Compounds for the Treatment of Neurodegenerative Diseases | BLANCHETTE ROCKEFELLER NEUROSCIENCES INSTITUTE (US) | 2010-01-28 | — | — | US | claimed |
| CN-101184513-A | Agents for controlling biological fluids and methods of use thereof | SOUTHEASTERN MEDICAL TECHNOLOG (US) | 2008-05-21 | — | — | CN | claimed |
| CN-101120916-A | Prostaglandin E2 injection and manufacturing method thereof | BEIJING RUZHAN BIOCHEMICAL PHA (CN) | 2008-02-13 | — | — | CN | claimed |
| CN-100363464-C | Application of high erucic acid rapeseed oil as raw material to prepare biodiesel oil and methyl erueidate | JINQING CHEN (CN) | 2008-01-23 | — | — | CN | claimed |
| WO-2006083434-A1 | USE OF ARACHIDONIC ACID AND ITS DERIVATIVES FOR INCREASING SKELETAL MUSCLE MASS | LLEWELLYN WILLIAM C (US) | 2006-08-10 | — | — | WO | claimed |
| CN-1786118-A | Application of high erucic acid rapeseed oil as raw material to prepare biodiesel oil and methyl erueidate | CHEN JINQING (CN) | 2006-06-14 | — | — | CN | claimed |
| US-20050137256-A1 | Use of arachidonic acid as a method of increasing skeletal muscle mass | LLEWELLYN WILLIAM C (US) | 2005-06-23 | — | — | US | claimed |
| EP-0926951-B1 | TREATING PULMONARY DISEASES MEDIATED BY POLYUNSATURATED LIPID METABOLITES AND ASSAYS FOR EPOXIDE HYDROLASE INHIBITORS | UNIV CALIFORNIA (US) | 2004-04-21 | — | — | EP | claimed |
| EP-0771599-B2 | Binder based on polyurethanes for producing foundry mould and core compositions | HUETTENES ALBERTUSCHEMISCHE WE (DE) | 2004-01-14 | — | — | EP | claimed |
| US-4832954-A | TRANSDERMAL CARDIOVASCULAR DRUGS | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1989-05-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100022645-A1 | PKC-Activating Compounds for the Treatment of Neurodegenerative Diseases | PRKCH, PRKCA, PRKCG | ALOX5 25/4885OXER1 499/4885MGLL 1015/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.